These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22095524)

  • 1. Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study.
    Ruzzenente A; Guglielmi A; Sandri M; Campagnaro T; Valdegamberi A; Conci S; Bagante F; Turcato G; D'Onofrio M; Iacono C
    J Gastrointest Surg; 2012 Feb; 16(2):301-11; discussion 311. PubMed ID: 22095524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.
    Ruzzenente A; Capra F; Pachera S; Iacono C; Piccirillo G; Lunardi M; Pistoso S; Valdegamberi A; D'Onofrio M; Guglielmi A
    J Gastrointest Surg; 2009 Jul; 13(7):1313-20. PubMed ID: 19418103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver resection versus microwave ablation for solitary and small (≤ 3 cm) HCC with early recurrence in different stages of liver cirrhosis: A propensity score matching study.
    Zhu RH; Huang Z; Xie ZH; Yuan T; Li J; Wang WQ; Lv X; Wang JL; Huang ZY; Zhang EL
    Asian J Surg; 2024 Jul; 47(7):3007-3014. PubMed ID: 38342723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis.
    Guglielmi A; Ruzzenente A; Valdegamberi A; Pachera S; Campagnaro T; D'Onofrio M; Martone E; Nicoli P; Iacono C
    J Gastrointest Surg; 2008 Jan; 12(1):192-8. PubMed ID: 17999123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Hepatocellular Carcinoma approached by curative-intent treatment: A propensity score analysis comparing radiofrequency ablation and liver resection.
    Di Sandro S; Benuzzi L; Lauterio A; Botta F; De Carlis R; Najjar M; Centonze L; Danieli M; Pezzoli I; Rampoldi A; Bagnardi V; De Carlis L
    Eur J Surg Oncol; 2019 Sep; 45(9):1691-1699. PubMed ID: 31072620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of Laparoscopic Approach for Resection of Liver Tumors in Cirrhotic Patients.
    Le Roux F; Rebibo L; Cosse C; Chatelain D; Nguyen-Khac E; Badaoui R; Regimbeau JM
    J Laparoendosc Adv Surg Tech A; 2018 May; 28(5):553-561. PubMed ID: 29350570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival.
    Guglielmi A; Ruzzenente A; Sandri M; Pachera S; Pedrazzani C; Tasselli S; Iacono C
    J Gastrointest Surg; 2007 Feb; 11(2):143-9. PubMed ID: 17390163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
    Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
    Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.
    Takayasu K; Arii S; Sakamoto M; Matsuyama Y; Kudo M; Kaneko S; Nakashima O; Kadoya M; Izumi N; Takayama T; Ku Y; Kumada T; Kubo S; Kokudo T; Hagiwara Y; Kokudo N;
    Liver Int; 2018 Mar; 38(3):484-493. PubMed ID: 29266722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of randomized trials and high-quality propensity score-matched studies.
    Hu L; Lin J; Wang A; Shi X; Qiao Y
    World J Surg Oncol; 2024 Feb; 22(1):56. PubMed ID: 38369480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis.
    Lee DH; Lee JM; Lee JY; Kim SH; Han JK; Choi BI
    Cardiovasc Intervent Radiol; 2014 Jun; 37(3):705-15. PubMed ID: 23912493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma.
    Su TS; Liang P; Liang J; Lu HZ; Jiang HY; Cheng T; Huang Y; Tang Y; Deng X
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):639-646. PubMed ID: 28581406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of hepatocellular carcinoma in Child-Pugh class B cirrhotic patients: hepatic resection and/or microwave coagulation therapy versus living donor liver transplantation.
    Harada N; Shirabe K; Ikeda Y; Korenaga D; Takenaka K; Maehara Y
    Ann Transplant; 2012 Dec; 17(4):11-20. PubMed ID: 23274319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients.
    Guglielmi A; Ruzzenente A; Battocchia A; Tonon A; Fracastoro G; Cordiano C
    Hepatogastroenterology; 2003; 50(50):480-4. PubMed ID: 12749252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver.
    Vivarelli M; Guglielmi A; Ruzzenente A; Cucchetti A; Bellusci R; Cordiano C; Cavallari A
    Ann Surg; 2004 Jul; 240(1):102-7. PubMed ID: 15213625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis.
    Santambrogio R; Opocher E; Zuin M; Selmi C; Bertolini E; Costa M; Conti M; Montorsi M
    Ann Surg Oncol; 2009 Dec; 16(12):3289-98. PubMed ID: 19727960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of laparoscopic versus open liver resection for hepatocellular carcinoma: a case-controlled study with propensity score matching.
    Kim H; Suh KS; Lee KW; Yi NJ; Hong G; Suh SW; Yoo T; Park MS; Choi Y; Lee HW
    Surg Endosc; 2014 Mar; 28(3):950-60. PubMed ID: 24149856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.